TYK-201
Hematological Malignancies
PreclinicalActive
Key Facts
About TYK Medicines
A clinical-stage biotech developing targeted small molecule therapies for oncology and immunology through structure-based drug design.
View full company profileTherapeutic Areas
Other Hematological Malignancies Drugs
| Drug | Company | Phase |
|---|---|---|
| NST-201 (estimated) | Novastage Pharmaceuticals | Preclinical/IND-enabling |
| TNB-655 | Tenacia Biotechnology | Preclinical |
| Undisclosed CAR-T Program | OBiO Technology | Phase 1/2 |
| NP-G2-044 | Novita Pharmaceuticals | Phase 2a |
| PS-102 | Perimeter Systems, Inc. | Preclinical |
| JaxBio Hematology Cancer Test | JaxBio | Preclinical |
| YZY-002 | YZY Biopharma | Phase 1 |